ELVN Working Capital Ratio

Enliven Therapeutics Inc · Working Capital Ratio

ELVN logo

ELVN Working Capital Ratio

Latest reported96.25%
ELVN FY Working Capital Ratio (91.92% → 96.25%)
High-resolution chart · PNG

ELVN working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
96.2496%
92.7714%
88.373%
81.6802%
92.5774%
92.6422%
79.3621%
76.2232%
91.9202%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.